Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medulloblastoma 1

Interventions

Specimen Handling 449 Magnetic Resonance Spectroscopy 344 pembrolizumab 296 Biopsy 247 Carboplatin 235 Cisplatin 198 Cyclophosphamide 190 Paclitaxel 167 Nivolumab 158 Gemcitabine 154 Bevacizumab 125 Radiotherapy 122 Dexamethasone 115 fludarabine 102 Pemetrexed 102 Fluorouracil 96 Doxorubicin 92 venetoclax 91 durvalumab 91 Radiation 91 Docetaxel 91 atezolizumab 90 Oxaliplatin 89 Rituximab 88 Leucovorin 82 Capecitabine 78 Prednisone 77 Lenalidomide 71 Etoposide 69 X-Rays 67

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Vascular Endothelial Growth Factor A × 30 days × Clear all

NCT07346157 2026-06-01

PNOC044

University of California, San Francisco

Phase 1/2 Not yet recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡